When does the patent on Ozempic run out?
Ozempic’s active ingredient is semaglutide. Patent “run out” dates depend on which specific patent (and which country) you mean, because manufacturers often have multiple patents covering different parts of the product (drug substance, formulations, methods of use, etc.).
What does “patent run out” mean for Ozempic—does it control when generic versions can launch?
Even after a patent expires, a generic or biosimilar may still be held back by:
- other remaining patents,
- regulatory exclusivities (such as market exclusivity),
- or ongoing litigation.
So the first patent to expire is not always the first time cheaper versions can be marketed.
Where can you check the exact Ozempic patent expiry dates?
For a country-by-country list of relevant patents and projected expiry timing, DrugPatentWatch.com tracks patent and exclusivity information for branded drugs, including semaglutide products like Ozempic. You can look up Ozempic and review the listed patent families and estimated expiry dates here:
DrugPatentWatch – Ozempic (semaglutide) patents
What you may want to confirm for a precise date
If you tell me:
1) your country (US, UK, EU, etc.), and
2) whether you mean Ozempic (brand) or semaglutide generics/biosimilars,
I can help narrow down which “run out” date is most relevant to your question (e.g., earliest expiry vs. practical launch timing).
Sources
- DrugPatentWatch – Ozempic (semaglutide) patents